Proteasomal degradation of TRIM5alpha during retrovirus restriction.

The host protein TRIM5alpha inhibits retroviral infection at an early post-penetration stage by targeting the incoming viral capsid. While the detailed mechanism of restriction remains unclear, recent studies have implicated the activity of cellular proteasomes in the restriction of retroviral rever...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Christopher James Rold, Christopher Aiken
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2008
Materias:
Acceso en línea:https://doaj.org/article/311c936a68f9460e884217fee707e3a9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:311c936a68f9460e884217fee707e3a9
record_format dspace
spelling oai:doaj.org-article:311c936a68f9460e884217fee707e3a92021-11-25T05:46:34ZProteasomal degradation of TRIM5alpha during retrovirus restriction.1553-73661553-737410.1371/journal.ppat.1000074https://doaj.org/article/311c936a68f9460e884217fee707e3a92008-05-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/18497858/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374The host protein TRIM5alpha inhibits retroviral infection at an early post-penetration stage by targeting the incoming viral capsid. While the detailed mechanism of restriction remains unclear, recent studies have implicated the activity of cellular proteasomes in the restriction of retroviral reverse transcription imposed by TRIM5alpha. Here, we show that TRIM5alpha is rapidly degraded upon encounter of a restriction-susceptible retroviral core. Inoculation of TRIM5alpha-expressing human 293T cells with a saturating level of HIV-1 particles resulted in accelerated degradation of the HIV-1-restrictive rhesus macaque TRIM5alpha protein but not the nonrestrictive human TRIM5alpha protein. Exposure of cells to HIV-1 also destabilized the owl monkey restriction factor TRIMCyp; this was prevented by addition of the inhibitor cyclosporin A and was not observed with an HIV-1 virus containing a mutation in the capsid protein that relieves restriction by TRIMCyp IVHIV. Likewise, human TRIM5alpha was rapidly degraded upon encounter of the restriction-sensitive N-tropic murine leukemia virus (N-MLV) but not the unrestricted B-MLV. Pretreatment of cells with proteasome inhibitors prevented the HIV-1-induced loss of both rhesus macaque TRIM5alpha and TRIMCyp proteins. We also detected degradation of endogenous TRIM5alpha in rhesus macaque cells following HIV-1 infection. We conclude that engagement of a restriction-sensitive retrovirus core results in TRIM5alpha degradation by a proteasome-dependent mechanism.Christopher James RoldChristopher AikenPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 4, Iss 5, p e1000074 (2008)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
spellingShingle Immunologic diseases. Allergy
RC581-607
Biology (General)
QH301-705.5
Christopher James Rold
Christopher Aiken
Proteasomal degradation of TRIM5alpha during retrovirus restriction.
description The host protein TRIM5alpha inhibits retroviral infection at an early post-penetration stage by targeting the incoming viral capsid. While the detailed mechanism of restriction remains unclear, recent studies have implicated the activity of cellular proteasomes in the restriction of retroviral reverse transcription imposed by TRIM5alpha. Here, we show that TRIM5alpha is rapidly degraded upon encounter of a restriction-susceptible retroviral core. Inoculation of TRIM5alpha-expressing human 293T cells with a saturating level of HIV-1 particles resulted in accelerated degradation of the HIV-1-restrictive rhesus macaque TRIM5alpha protein but not the nonrestrictive human TRIM5alpha protein. Exposure of cells to HIV-1 also destabilized the owl monkey restriction factor TRIMCyp; this was prevented by addition of the inhibitor cyclosporin A and was not observed with an HIV-1 virus containing a mutation in the capsid protein that relieves restriction by TRIMCyp IVHIV. Likewise, human TRIM5alpha was rapidly degraded upon encounter of the restriction-sensitive N-tropic murine leukemia virus (N-MLV) but not the unrestricted B-MLV. Pretreatment of cells with proteasome inhibitors prevented the HIV-1-induced loss of both rhesus macaque TRIM5alpha and TRIMCyp proteins. We also detected degradation of endogenous TRIM5alpha in rhesus macaque cells following HIV-1 infection. We conclude that engagement of a restriction-sensitive retrovirus core results in TRIM5alpha degradation by a proteasome-dependent mechanism.
format article
author Christopher James Rold
Christopher Aiken
author_facet Christopher James Rold
Christopher Aiken
author_sort Christopher James Rold
title Proteasomal degradation of TRIM5alpha during retrovirus restriction.
title_short Proteasomal degradation of TRIM5alpha during retrovirus restriction.
title_full Proteasomal degradation of TRIM5alpha during retrovirus restriction.
title_fullStr Proteasomal degradation of TRIM5alpha during retrovirus restriction.
title_full_unstemmed Proteasomal degradation of TRIM5alpha during retrovirus restriction.
title_sort proteasomal degradation of trim5alpha during retrovirus restriction.
publisher Public Library of Science (PLoS)
publishDate 2008
url https://doaj.org/article/311c936a68f9460e884217fee707e3a9
work_keys_str_mv AT christopherjamesrold proteasomaldegradationoftrim5alphaduringretrovirusrestriction
AT christopheraiken proteasomaldegradationoftrim5alphaduringretrovirusrestriction
_version_ 1718414450560598016